The stock of Edesa Biotech Inc (EDSA) has gone up by 40.71% for the week, with a 53.71% rise in the past month and a 12.52% rise in the past quarter. The volatility ratio for the week is 19.49%, and the volatility levels for the past 30 days are 12.83% for EDSA. The simple moving average for the last 20 days is 33.92% for EDSA’s stock, with a simple moving average of -24.67% for the last 200 days.
Is It Worth Investing in Edesa Biotech Inc (NASDAQ: EDSA) Right Now?
The 36-month beta value for EDSA is also noteworthy at 0.79. There are mixed opinions on the stock, with 0 analysts rating it as a “buy,” 1 rating it as “overweight,” 0 rating it as “hold,” and 0 rating it as “sell.”
The public float for EDSA is 2.36M, and at present, short sellers hold a 0.72% of that float. The average trading volume of EDSA on February 17, 2025 was 1.92M shares.
EDSA) stock’s latest price update
The stock of Edesa Biotech Inc (NASDAQ: EDSA) has decreased by -17.23 when compared to last closing price of 3.25.Despite this, the company has seen a gain of 40.71% in its stock price over the last five trading days. globenewswire.com reported 2025-02-14 that TORONTO, Feb. 14, 2025 (GLOBE NEWSWIRE) — Edesa Biotech, Inc. (Nasdaq:EDSA), a clinical-stage biopharmaceutical company focused on developing host-directed therapeutics for immuno-inflammatory diseases, today reported financial results for the three months ended December 31, 2024 and provided an update on its business.
EDSA Trading at 40.57% from the 50-Day Moving Average
After a stumble in the market that brought EDSA to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -55.09% of loss for the given period.
Volatility was left at 12.83%, however, over the last 30 days, the volatility rate increased by 19.49%, as shares surge +59.17% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading +13.50% upper at present.
During the last 5 trading sessions, EDSA rose by +40.71%, which changed the moving average for the period of 200-days by -38.44% in comparison to the 20-day moving average, which settled at $2.01. In addition, Edesa Biotech Inc saw 60.12% in overturn over a single year, with a tendency to cut further gains.
Insider Trading
Reports are indicating that there were more than several insider trading activities at EDSA starting from Nijhawan Pardeep, who purchase 5,000 shares at the price of $4.00 back on Mar 25 ’24. After this action, Nijhawan Pardeep now owns 341,702 shares of Edesa Biotech Inc, valued at $20,000 using the latest closing price.
Stock Fundamentals for EDSA
The total capital return value is set at -3.12. Equity return is now at value -136.66, with -94.46 for asset returns.
Currently, EBITDA for the company is -6.13 million with net debt to EBITDA at 0.25. The liquidity ratio also appears to be rather interesting for investors as it stands at 0.91.
Conclusion
In summary, Edesa Biotech Inc (EDSA) has had a better performance as of late. Analysts have mixed opinions on the stock, with some viewing it as a “buy” and others as a “hold”. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
